Cytokinetics (CYTK) had the highest return between December 23, 2023 and December 31, 2023 by a US stock with a market cap of $2B+, returning 86.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Cytokinetics (CYTK) | 12/23/2023 - 12/31/2023 | 86.61% |
QXO (QXO) | 12/23/2023 - 12/31/2023 | 56.11% |
WM Technology (MAPSW) | 12/23/2023 - 12/31/2023 | 31% |
EchoStar (SATS) | 12/23/2023 - 12/31/2023 | 15.87% |
Burford Capital (BUR) | 12/23/2023 - 12/31/2023 | 14.96% |
BigBearai (BBAI) | 12/23/2023 - 12/31/2023 | 14.44% |
Grifols SA ADR (GRFS) | 12/23/2023 - 12/31/2023 | 11.37% |
Terawulf (WULF) | 12/23/2023 - 12/31/2023 | 11.11% |
Immunitybio (IBRX) | 12/23/2023 - 12/31/2023 | 11.06% |
Summit Therapeutics (SMMT) | 12/23/2023 - 12/31/2023 | 10.59% |
Regencell Bioscience (RGC) | 12/23/2023 - 12/31/2023 | 10.52% |
Celsius (CELH) | 12/23/2023 - 12/31/2023 | 9.02% |
Grupo Aval (AVAL) | 12/23/2023 - 12/31/2023 | 8.84% |
Emera (EMA) | 12/23/2023 - 12/31/2023 | 8.53% |
Bilibili (BILI) | 12/23/2023 - 12/31/2023 | 8.18% |
Lufax (LU) | 12/23/2023 - 12/31/2023 | 8.1% |
IHS (IHS) | 12/23/2023 - 12/31/2023 | 7.98% |
Bausch Health Companies (BHC) | 12/23/2023 - 12/31/2023 | 7.94% |
Verona Pharma PLC ADR (VRNA) | 12/23/2023 - 12/31/2023 | 7.93% |
Zai Lab (ZLAB) | 12/23/2023 - 12/31/2023 | 7.81% |
BGC (BGC) | 12/23/2023 - 12/31/2023 | 7.6% |
GDS (GDS) | 12/23/2023 - 12/31/2023 | 7.29% |
Sharplink Gaming (SBET) | 12/23/2023 - 12/31/2023 | 7.14% |
Bausch + Lomb (BLCO) | 12/23/2023 - 12/31/2023 | 6.96% |
HUTCHMED DRC (HCM) | 12/23/2023 - 12/31/2023 | 6.84% |
